Palantir's 13% Weekly Surge Obscures a Twin Governance Storm: NHS Data Scrutiny and Norway's Proxy Rebellion

Palantir stock rallies 9% on Dell AI partnership, but faces UK NHS data access inquiry and Norway's $2.3T fund backing human rights audit proposals.

For a stock that just delivered its best single-day gain in a year, Palantir Technologies faces an unusually thicket of non-financial headwinds this week. The company's shares rocketed 9.04% on Friday to close at €134.18, fuelled by a blowout earnings report from Dell Technologies that confirmed the strength of their AI partnership. The weekly gain stood at nearly 13%, and volumes surged to 92.2 million shares — more than double the daily average. Yet beneath that rally, two separate governance flashpoints are converging on London and the shareholder meeting scheduled for June 3.

The NHS Data Access Question

In the British House of Commons on May 28, Health Minister Preet Kaur Gill faced a pointed inquiry from Liberal Democrat MP Martin Wrigley. The question, prompted by a Financial Times report, concerned whether NHS England had created an administrative role that gave external contractors — including Palantir employees — access to identifiable patient data before pseudonymisation on the National Data Integration Tenant. Gill's answer was circumspect: high-value access rights on the NHS Federated Data Platform had not been expanded, and NHS England had found no adverse effects from the current access controls. Permissions, she said, remained role- and purpose-bound.

The issue matters to investors because the NHS contract ranks among the most politically sensitive public-sector AI deals in Palantir's international portfolio. The UK accounts for roughly 8% of total revenue — $130.1 million in the first quarter — but the governance debate around health data could set a precedent for how European governments balance innovation with privacy. Palantir's own data protection policies bar the platform operator from using data for its own purposes and mandate de-identification as part of the confidentiality framework.

Norway's $2.3 Trillion Voice

Across the North Sea, a different kind of pressure is building. Norges Bank Investment Management, which runs the world's largest sovereign wealth fund at $2.3 trillion, announced it will vote in favour of two shareholder proposals at Palantir's annual general meeting on June 3 — a resolution calling for an independent audit of potential human rights violations linked to Palantir's technology, and a second requiring a report on the company's political donations. Both are opposed by Palantir's board, which argues that it is not a surveillance company, does not trade in personal data, and cannot disclose more due to legal and confidentiality constraints.

Norway is not acting alone. In February, the New York City Council demanded Palantir conduct an independent risk analysis of its work with the Department of Homeland Security and Immigration and Customs Enforcement. The Netherlands' largest pension fund, ABP, has fully divested its Palantir holdings. Investor Advocates for Social Justice filed an SEC submission in May supporting the human rights audit, and institutional investors representing $336 billion in assets under management have joined the campaign.

The timing is notable. Norway loosened parts of its ethical rules for the sovereign fund in 2025 — a move critics saw as shielding technology companies with Israel-related business — while simultaneously building its Palantir position. The vote allows the fund to express concern without relinquishing the stake.

Financials That Command Attention

The governance debates land against a backdrop of extraordinary financial performance. First-quarter 2026 revenue hit $1.633 billion, an 85% year-over-year surge. US revenue climbed 104% to $1.282 billion, while US commercial revenue jumped 133% to $595 million. Operating GAAP profit reached $754 million, and adjusted free cash flow stood at $925 million. Management raised full-year 2026 guidance to a range of $7.650 billion to $7.662 billion, implying 71% growth.

Yet the valuation leaves little margin for error. With a price-to-earnings multiple of roughly 176 and a market capitalisation of about $402 billion, the stock already discounts years of above-trend expansion. At such multiples, non-financial headlines can reverberate more sharply than they would for a run-of-the-mill software firm.

What the Rally Hides

Friday's jump was triggered not by a Palantir-specific catalyst but by Dell's blockbuster AI-server numbers, which validated Palantir's integration into Dell's AI Factory. A broader software-sector rally, sparked by strong results from Snowflake — another Palantir partner — added momentum. Over the past ten trading sessions, Palantir gained on seven, pushing the two-week return to 17.06%. The relative strength index now sits at 89.9, deep in overbought territory.

The all-time high of €179.86, set on November 3, 2025, remains 25.40% above Friday's close. Year to date, the stock is still down 6.23%.

The Longer View

The Pentagon's recent designation of Palantir's Maven AI system as an official programme, along with contract extensions from the US Army and the Department of Agriculture, underscore the durability of government demand. But as the NHS and Norway episodes show, the political price of those contracts is rising. Whether regulators and institutional shareholders accept that an external software vendor can handle sensitive health data under strict conditions will help determine how quickly regulated enterprise AI scales in Europe — and how steep the governance premium becomes for companies like Palantir.

Analysts expect second-quarter 2026 earnings per share of $0.33, with results due on August 3. Until then, the stock's trajectory may depend less on AI adoption curves and more on how well the company navigates the gap between its technological promise and the scrutiny it increasingly attracts.